药物短缺的原因和管理:一个范围审查
N Cornelissen1, S W Zielhuis2, P M L A van den Bemt3
1Department of Pharmacy, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD, Delft, the Netherlands; Department of Pharmacy, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA, Nijmegen, the Netherlands.
Research in social & administrative pharmacy : RSAP
|October 30, 2025
概括
药物短缺源于制造,需求和供应链问题. 目前的管理策略是反应性的,重点是晚期干预,而不是早期预防.
科学领域:
- 制药科学 制药科学
- 卫生政策 卫生政策
- 供应链管理 供应链管理
背景情况:
- 药物短缺是一个重大的全球挑战,影响了治疗,成本和患者的治疗结果.
- 了解药物短缺的根本原因对于制定有效的预防和管理策略至关重要.
- 这一范围审查侧重于药物短缺的原因和管理,特别是在高收入国家.
研究的目的:
- 提供药物短缺确定的原因的全面概述.
- 审查目前的药物短缺管理策略和干预措施.
- 分析短缺的来源与实施的管理方法之间的协调.
主要方法:
- 按照JBI的方法进行系统的范围审查.
- 在2023年12月21日之前进行广泛的数据库搜索 (PubMed,EMBASE,Web of Science,CENTRAL).
- 包括英语/荷兰语关于高收入国家药物短缺的研究,以独立的数据提取和描述性分析.
主要成果:
- 包括36项研究,确定了制造问题,需求波动,供应链缺陷和战略决策等原因.
- 药物短缺的根本原因往往是未知的.
- 干预措施包括替代药物,库存控制,改善沟通,监管行动和预测,通常是反应地实施的.
结论:
- 目前的干预措施主要解决供应链后期问题,提供临时解决方案.
- 药物短缺通常起源于产品生命周期的早期阶段.
- 转向解决早期原因是必要的,以开发更有效和预防性的药物短缺解决方案.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Drug Control Governance: Regulatory Bodies and Their Impact
481
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
481
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Dosage Regimens: Partial Pharmacokinetic Parameters
144
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
144
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
172
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
172


